October 1, 2024 Investor Beware: Port Strike Puts Key Stocks And Sectors At Risk
September 30, 2024 Market Movers: Jobs Report and Key Earnings in Focus
September 19, 2024 Federal Reserve’s Aggressive Move Hints At Bold Economic Strategy
The Biggest Problem With Nvidia’s Stock That Everyone Is Missing
Amazon Is Firing On All Cylinders
Tesla’s Robotaxi: Hype Meets Reality – Maintain Hold
Tesla: The 10/10 Moment Of Truth For Robotaxis
October 3, 2024 Your Path to Profits: The Best Trading Platforms for New Traders
October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
Biohaven Pharmaceutical Holding (BHVN) stock forecast for 2025
Updated: October 12, 2024 (14:36)
Sector: HealthcareThe share price of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) now
50/200 Day Moving Average: $41.51 / $42.87
This figure corresponds to the Average Price over the previous 50/200 days. For Biohaven Pharmaceutical Holding stocks, the 50-day moving average is the resistance level today.
For Biohaven Pharmaceutical Holding stocks, the 200-day moving average is the resistance level today.
Are you interested in Biohaven Pharmaceutical Holding Company Ltd. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Biohaven Pharmaceutical Holding stock price in 2025. How much will one Biohaven Pharmaceutical Holding share be worth in 2025? Is it worth taking profit / loss on BHVN stock now or waiting? What are analysts' forecasts for Biohaven Pharmaceutical Holding stock?
We forecast Biohaven Pharmaceutical Holding stock performance using neural networks based on historical data on BHVN stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Biohaven Pharmaceutical Holding Company Ltd. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Biohaven Pharmaceutical Holding analysts is $63.38. Today 200 Day Moving Average is the support level (42.87 $). 50 Day Moving Average is the support level (41.51 $).
Historical and forecast chart of Biohaven Pharmaceutical Holding Company Ltd. stock
The chart below shows the historical price of Biohaven Pharmaceutical Holding stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the BHVN stock price can be found in the table below.
Biohaven Pharmaceutical Holding Company Ltd., a clinical stage biopharmaceutical company, is developing advanced candidate products targeting neurological diseases and rare disorders in the United States. Its clinical stage products include Rimehepant, a product that has completed phase III trials for the acute treatment and prevention of migraines; Vasegepant, which has completed phase 2/3 trials for acute treatment and prevention of migraine; and Troriluzole, which has completed phase II / III randomization and is continuing with extended trials for ataxia. The company also offers Troril uzole, which is a phase II / III clinical stage for obsessive-compulsive disorder and Alzheimer’s disease; BHV-0223, product for amyotrophic lateral sclerosis; BHV-5000, a product that has completed phase I clinical trials for neuropsychiatric disorders; and Verdiperstat, a product that is in phase III clinical trials for multiple systemic atrophy. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine assessment of migraine sufferers. The company was founded in 2013 and is headquartered in New Haven, Connecticut.
Biohaven Pharmaceutical Holding (BHVN) Forecast for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 55.96 | 53.99 | 58.05 | 7.00 % |
| Feb | 54.48 | 51.91 | 58.50 | 11.27 % |
| Mar | 55.50 | 51.11 | 58.13 | 12.08 % |
| Apr | 57.76 | 52.81 | 59.86 | 11.78 % |
| May | 56.36 | 53.39 | 57.79 | 7.62 % |
| Jun | 56.61 | 54.25 | 58.23 | 6.84 % |
| Jul | 58.23 | 54.20 | 61.50 | 11.87 % |
| Aug | 55.41 | 52.49 | 59.44 | 11.69 % |
| Sep | 52.79 | 48.67 | 55.23 | 11.88 % |
| Oct | 51.57 | 48.06 | 55.09 | 12.77 % |
| Nov | 56.39 | 52.05 | 60.36 | 13.77 % |
| Dec | 57.45 | 54.86 | 59.98 | 8.53 % |
Biohaven Pharmaceutical Holding information and performance
215 CHURCH STREET, NEW HAVEN, CT, US
Market capitalization of the Biohaven Pharmaceutical Holding Company Ltd. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BHVN shares in the company outstanding by the market price of one share.
EBITDA of Biohaven Pharmaceutical Holding is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Biohaven Pharmaceutical Holding price target for 2025 by month
Target values for the price of one Biohaven Pharmaceutical Holding share for Jan 2025.
In Jan, the Positive dynamics for Biohaven Pharmaceutical Holding Company Ltd. shares will prevail with possible monthly volatility of 6.998% volatility is expected.
Pessimistic target level: 53.99
Optimistic target level: 58.05
Target values for the price of one Biohaven Pharmaceutical Holding share for Feb 2025.
In Feb, the Negative dynamics for Biohaven Pharmaceutical Holding Company Ltd. shares will prevail with possible monthly volatility of 11.269% volatility is expected.
Pessimistic target level: 51.91
Optimistic target level: 58.50
Target values for the price of one Biohaven Pharmaceutical Holding share for Mar 2025.
In Mar, the Positive dynamics for Biohaven Pharmaceutical Holding Company Ltd. shares will prevail with possible monthly volatility of 12.079% volatility is expected.
Pessimistic target level: 51.11
Optimistic target level: 58.13
Target values for the price of one Biohaven Pharmaceutical Holding share for Apr 2025.
In Apr, the Positive dynamics for Biohaven Pharmaceutical Holding Company Ltd. shares will prevail with possible monthly volatility of 11.782% volatility is expected.
Pessimistic target level: 52.81
Optimistic target level: 59.86
Target values for the price of one Biohaven Pharmaceutical Holding share for May 2025.
In May, the Negative dynamics for Biohaven Pharmaceutical Holding Company Ltd. shares will prevail with possible monthly volatility of 7.617% volatility is expected.
Pessimistic target level: 53.39
Optimistic target level: 57.79
Target values for the price of one Biohaven Pharmaceutical Holding share for Jun 2025.
In Jun, the Positive dynamics for Biohaven Pharmaceutical Holding Company Ltd. shares will prevail with possible monthly volatility of 6.844% volatility is expected.
Pessimistic target level: 54.25
Optimistic target level: 58.23
Target values for the price of one Biohaven Pharmaceutical Holding share for Jul 2025.
In Jul, the Positive dynamics for Biohaven Pharmaceutical Holding Company Ltd. shares will prevail with possible monthly volatility of 11.874% volatility is expected.
Pessimistic target level: 54.20
Optimistic target level: 61.50
Target values for the price of one Biohaven Pharmaceutical Holding share for Aug 2025.
In Aug, the Negative dynamics for Biohaven Pharmaceutical Holding Company Ltd. shares will prevail with possible monthly volatility of 11.691% volatility is expected.
Pessimistic target level: 52.49
Optimistic target level: 59.44
Target values for the price of one Biohaven Pharmaceutical Holding share for Sep 2025.
In Sep, the Negative dynamics for Biohaven Pharmaceutical Holding Company Ltd. shares will prevail with possible monthly volatility of 11.881% volatility is expected.
Pessimistic target level: 48.67
Optimistic target level: 55.23
Target values for the price of one Biohaven Pharmaceutical Holding share for Oct 2025.
In Oct, the Negative dynamics for Biohaven Pharmaceutical Holding Company Ltd. shares will prevail with possible monthly volatility of 12.769% volatility is expected.
Pessimistic target level: 48.06
Optimistic target level: 55.09
Target values for the price of one Biohaven Pharmaceutical Holding share for Nov 2025.
In Nov, the Positive dynamics for Biohaven Pharmaceutical Holding Company Ltd. shares will prevail with possible monthly volatility of 13.771% volatility is expected.
Pessimistic target level: 52.05
Optimistic target level: 60.36
Target values for the price of one Biohaven Pharmaceutical Holding share for Dec 2025.
In Dec, the Positive dynamics for Biohaven Pharmaceutical Holding Company Ltd. shares will prevail with possible monthly volatility of 8.534% volatility is expected.
Pessimistic target level: 54.86
Optimistic target level: 59.98
Related stocks from Healthcare sector
